2007
DOI: 10.1111/j.1399-3038.2007.00600.x
|View full text |Cite
|
Sign up to set email alerts
|

Neutrophil but not eosinophil inflammation is related to the severity of a first acute epidemic bronchiolitis in young infants

Abstract: Acute bronchiolitis is the main cause of emergency visits and hospitalizations in infants. Recent data suggest that neutrophil- and eosinophil-mediated inflammations were part of bronchiolitis pathophysiology. Apart from the defined risk factors, few was known on the underlying pathophysiology, which might point out the differences observed in the severity of the disease. The aim of this study was to assess whether the clinical severity of acute epidemic bronchiolitis in young infants might be related to a spe… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

0
26
0

Year Published

2010
2010
2021
2021

Publication Types

Select...
7
2

Relationship

0
9

Authors

Journals

citations
Cited by 36 publications
(26 citation statements)
references
References 49 publications
(100 reference statements)
0
26
0
Order By: Relevance
“…Therefore, there is a need to identify other pharmacological interventions that could be used in children hospitalized with RSV bronchiolitis that may prevent subsequent recurrent wheezing. Conventional asthma controller medications have shown to have limited to no efficacy for the prevention of post-RSV recurrent wheezing 1320 , possibly related to their limited effect on neutrophilic airway inflammation that predominate the inflammatory process during viral bronchiolitis 22, 23, 34 . Therefore, a medication with anti-neutrophilic properties has the mechanistic rationale to serve as an intervention for the prevention of post-RSV recurrent wheezing.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Therefore, there is a need to identify other pharmacological interventions that could be used in children hospitalized with RSV bronchiolitis that may prevent subsequent recurrent wheezing. Conventional asthma controller medications have shown to have limited to no efficacy for the prevention of post-RSV recurrent wheezing 1320 , possibly related to their limited effect on neutrophilic airway inflammation that predominate the inflammatory process during viral bronchiolitis 22, 23, 34 . Therefore, a medication with anti-neutrophilic properties has the mechanistic rationale to serve as an intervention for the prevention of post-RSV recurrent wheezing.…”
Section: Discussionmentioning
confidence: 99%
“…Numerous trials using treatments typically used for asthma, such as inhaled corticosteroids (ICS) 1315 , systemic corticosteroids 1618 , and montelukast 19, 20 have shown to have limited to no effect on the occurrence of post-bronchiolitis wheezing. These medications have minimal effect on non-eosinophilic airway inflammation 21 , the dominant pattern seen during bronchiolitis 22, 23 , and this may explain lack of efficacy of these treatments on post-bronchiolitis wheezing.…”
Section: Introductionmentioning
confidence: 99%
“…Strong lung neutrophil recruitment is also observed in animal pneumovirus disease, such as bovine RSV infection in calves and pneumonia virus of mice (PVM) in rodents [7]. Both human and animal pneumovirus infections elicit prominent CXC chemokine responses, including CXCL-8 [8, 9] and KC [10], which likely contribute to the neutrophilic inflammation. However, so far it is unknown if these high numbers of neutrophils in the airways and lungs are solely protective or may also be detrimental during pneumovirus infections.…”
Section: Introductionmentioning
confidence: 99%
“…Current clinical prediction rules are based on demographic criteria and clinical symptoms [3][4][5][6][7][8][9][10] and although they may improve clinical judgement [7,8], they are not routinely used in daily practice. More objective and reproducible predictions may be achieved by using biomarkers [11][12][13][14][15].…”
Section: Introductionmentioning
confidence: 99%